Loss of phosphatase and tensin homolog expression castration‐sensitive prostate cancer predicts outcomes in men after prostatectomy

Yoshinori Yanai,Shuji Mikami,Yota Yasumizu,Toshikazu Takeda,Kazuhiro Matsumoto,Shigehisa Kitano,Mototsugu Oya,Takeo Kosaka
DOI: https://doi.org/10.1111/iju.15592
2024-10-02
International Journal of Urology
Abstract:Objectives This study aimed to investigate the potential for using the phosphatase and tensin homolog (PTEN) gene as a prognostic marker in post‐prostatectomy patients with castration‐sensitive prostate cancer (PCa). Methods A total of 180 patients with castration‐sensitive PCa who underwent radical prostatectomy at our institution were included in this study. PTEN expression was evaluated using immunohistochemistry, and patients were classified into two groups based on the staining intensity: PTEN‐Normal and PTEN‐Loss. The association between PTEN expression and biochemical recurrence was analyzed using the Cox proportional hazards model. Results Patients in the PTEN‐Loss group had a higher risk of biochemical recurrence (hazard ratio, 4.642; 95% confidence interval, 2.137–10.083; p
urology & nephrology
What problem does this paper attempt to address?